CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,489,350 | -30.8% | 165,000 | -14.5% | 0.02% | -37.5% |
| Q2 2023 | $10,829,406 | -46.8% | 192,900 | -57.2% | 0.03% | -27.3% |
| Q1 2023 | $20,367,069 | +15.0% | 450,300 | +3.4% | 0.04% | -12.0% |
| Q4 2022 | $17,711,205 | -41.5% | 435,700 | -5.9% | 0.05% | -45.7% |
| Q3 2022 | $30,257,000 | +49.7% | 463,000 | +39.2% | 0.09% | +41.5% |
| Q2 2022 | $20,206,000 | +35.3% | 332,500 | +39.7% | 0.06% | +38.3% |
| Q1 2022 | $14,939,000 | +173.9% | 238,000 | +230.6% | 0.05% | +161.1% |
| Q4 2021 | $5,455,000 | -40.0% | 71,993 | -11.4% | 0.02% | -45.5% |
| Q3 2021 | $9,098,000 | -29.9% | 81,282 | +1.4% | 0.03% | -35.3% |
| Q2 2021 | $12,979,000 | +63.4% | 80,172 | +23.0% | 0.05% | +45.7% |
| Q1 2021 | $7,944,000 | +153.2% | 65,200 | +218.0% | 0.04% | +150.0% |
| Q4 2020 | $3,138,000 | +207.6% | 20,500 | +68.0% | 0.01% | +180.0% |
| Q3 2020 | $1,020,000 | +7.6% | 12,200 | -5.4% | 0.01% | -16.7% |
| Q2 2020 | $948,000 | -15.0% | 12,900 | -51.0% | 0.01% | -33.3% |
| Q1 2020 | $1,115,000 | -82.3% | 26,300 | -74.5% | 0.01% | -79.1% |
| Q4 2019 | $6,287,000 | +133.8% | 103,218 | +57.3% | 0.04% | +95.5% |
| Q3 2019 | $2,689,000 | +34.0% | 65,615 | +54.0% | 0.02% | +29.4% |
| Q2 2019 | $2,007,000 | +260.3% | 42,600 | +173.1% | 0.02% | +240.0% |
| Q1 2019 | $557,000 | -73.0% | 15,600 | -78.4% | 0.01% | -64.3% |
| Q4 2018 | $2,063,000 | +1189.4% | 72,191 | +1905.3% | 0.01% | +1300.0% |
| Q3 2018 | $160,000 | – | 3,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |